DI-009 Non-valvular atrial fibrillation: criteria for prescription of novel oral anticoagulants

DI-009 Non-valvular atrial fibrillation: criteria for prescription of novel oral anticoagulants

BackgroundNon-valvular atrial fibrillation (NVAF) is the most common cardiac arrhythmia in clinical practice, affecting nearly 1% of the general population.1 In Spain, the stipulated recommendations to select anticoagulant are: use of novel oral anticoagulants (NOACs) in case of poor international n...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of hospital pharmacy. Science and practice 2017-03, Vol.24 (Suppl 1), p.A116-A116
Hauptverfasser: Torne, G Rodriguez, Medina, M Gonzalez, Martinez, D Blanquez
Format: Artikel
Sprache:eng
Schlagworte:
Anticoagulants
Cardiac arrhythmia
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BackgroundNon-valvular atrial fibrillation (NVAF) is the most common cardiac arrhythmia in clinical practice, affecting nearly 1% of the general population.1 In Spain, the stipulated recommendations to select anticoagulant are: use of novel oral anticoagulants (NOACs) in case of poor international normalised ratio (INR) control (
ISSN:2047-9956
2047-9964
DOI:10.1136/ejhpharm-2017-000640.256